Myocardial Perfusion Imaging in Liver Transplantation Candidates
NCT ID: NCT03864497
Last Updated: 2019-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
403 participants
OBSERVATIONAL
2007-09-30
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Strain Using Speckle Tracking Echocardiography During Orthotopic Liver Transplantation
NCT04316468
Hemodynamic Measurements During Liver Transplantation
NCT00682110
Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function
NCT03814031
Right Ventricular Function During Liver Transplantation as Assessed by Transesophageal Echocardiography.
NCT03459924
Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study
NCT04112953
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Orthotopic liver transplantation candidates
No intervention, imaging test and risk stratification as part of routine clinical care.
Myocardial perfusion imaging
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Myocardial perfusion imaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* inability to perform \>4 METs by history
* insulin-treated diabetes mellitus
* serum creatinine \>152μmol/l
* history of MI, PCI or CABG
* stable angina
* cerebrovascular disease
* peripheral vascular disease
Exclusion Criteria
* Pregnancy
* Contraindication to liver transplantation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Birmingham NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William E Moody
Consultant Cardiologist with a Specialist Interest in Cardiac Imaging
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard P Steeds, MD
Role: STUDY_DIRECTOR
University Hospital Birmingham NHS Foundation Trust
References
Explore related publications, articles, or registry entries linked to this study.
Moody WE, Holloway B, Arumugam P, Gill S, Wahid YS, Boivin CM, Thomson LE, Berman DS, Armstrong MJ, Ferguson J, Steeds RP. Prognostic value of coronary risk factors, exercise capacity and single photon emission computed tomography in liver transplantation candidates: A 5-year follow-up study. J Nucl Cardiol. 2021 Dec;28(6):2876-2891. doi: 10.1007/s12350-020-02126-z. Epub 2020 May 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CARMS-14536
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.